Terms: = Lung cancer AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E
373 results:
1. Association of ccnd1 rs9344 polymorphism with lung cancer susceptibility and clinical outcomes: a case-control study.
Mei C; Wang T; Xu B; Wu S; Zhang X; Lv Y; Zhang Y; Liu Z; Gong W
BMC Pulm Med; 2024 Apr; 24(1):167. PubMed ID: 38589850
[TBL] [Abstract] [Full Text] [Related]
2. Utility of molecular markers in predicting local control specific to lung cancer spine metastases treated with stereotactic body radiotherapy.
Shor D; Louie AV; Zeng KL; Menjak IB; Atenafu EG; Chia-Lin Tseng ; Detsky J; Larouche J; Zhang B; Soliman H; Myrehaug S; Maralani P; Hwang DM; Sahgal A; Chen H
J Neurooncol; 2024 Apr; 167(2):275-283. PubMed ID: 38526757
[TBL] [Abstract] [Full Text] [Related]
3. Assessing the causal relationship between 731 immunophenotypes and the risk of lung cancer: a bidirectional mendelian randomization study.
Xu M; Li C; Xiang L; Chen S; Chen L; Ling G; Hu Y; Yang L; Yuan X; Xia X; Zhang H
BMC Cancer; 2024 Feb; 24(1):270. PubMed ID: 38408977
[TBL] [Abstract] [Full Text] [Related]
4. Comparison of Clinical and Genetic Characteristics Between Younger and Older lung cancer Patients.
Candal-Pedreira C; Ruano-Ravina A; Calvo de Juan V; Cobo M; Trigo JM; Rodríguez-Abreu D; Estival A; Carcereny E; Cucurull M; López Castro R; Medina A; García Campelo R; Cordeiro González P; Sánchez-Gastaldo A; Bosch-Barrera J; Massutí B; Dómine M; Camps C; Ortega AL; Sánchez-Hernández A; Guirado Risueño M; Del Barco Morillo E; Garrido Fernández A; Provencio M
Arch Bronconeumol; 2024 Feb; 60(2):88-94. PubMed ID: 38160163
[TBL] [Abstract] [Full Text] [Related]
5. Real-World comprehensive genomic profiling data for diagnostic clarity in pulmonary Large-Cell neuroendocrine carcinoma.
Burns L; Tukachinsky H; Raskina K; Huang RSP; Schrock AB; Sands J; Kulke MH; Oxnard GR; Tapan U
Lung Cancer; 2024 Feb; 188():107454. PubMed ID: 38159439
[TBL] [Abstract] [Full Text] [Related]
6. High SNHG expression may predict a poor lung cancer prognosis based on a meta-analysis.
Shen GY; Huang RZ; Yang SB; Shen RQ; Gao JL; Zhang Y
BMC Cancer; 2023 Dec; 23(1):1243. PubMed ID: 38104110
[TBL] [Abstract] [Full Text] [Related]
7. Long-Term Intracranial Outcomes With Combination Dual Immune-Checkpoint Blockade and Stereotactic Radiosurgery in Patients With Melanoma and Non-Small Cell lung cancer Brain Metastases.
Vaios EJ; Shenker RF; Hendrickson PG; Wan Z; Niedzwiecki D; Winter SF; Shih HA; Dietrich J; Wang C; Salama AKS; Clarke JM; Allen K; Sperduto P; Mullikin T; Kirkpatrick JP; Floyd SR; Reitman ZJ
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1507-1518. PubMed ID: 38097090
[TBL] [Abstract] [Full Text] [Related]
8. LINC00921 reduces lung cancer radiosensitivity by destabilizing NUDT21 and driving aberrant MED23 alternative polyadenylation.
Zhang N; Liu X; Huang L; Zeng J; Ma C; Han L; Li W; Yu J; Yang M
Cell Rep; 2023 Dec; 42(12):113479. PubMed ID: 37999979
[TBL] [Abstract] [Full Text] [Related]
9. [Study of genetic variants in 169 non-small cell lung cancer patients].
Formanti Alonso L; Atienza Cuevas L; Romero García R; Mohigefer Barrera J; Del Río Ignacio JJ; Santisteban Espejo A; Bernal Florindo I; Catalina Fernández I; García Rojo M
Rev Esp Patol; 2023; 56(4):233-242. PubMed ID: 37879820
[TBL] [Abstract] [Full Text] [Related]
10. Dual network analysis of transcriptome data for discovery of new therapeutic targets in non-small cell lung cancer.
Bai Y; Zhou L; Zhang C; Guo M; Xia L; Tang Z; Liu Y; Deng S
Oncogene; 2023 Dec; 42(49):3605-3618. PubMed ID: 37864031
[TBL] [Abstract] [Full Text] [Related]
11. Pathway-driven analysis of synthetic lethal interactions in cancer using perturbation screens.
Karimpour M; Totonchi M; Behmanesh M; Montazeri H
Life Sci Alliance; 2024 Jan; 7(1):. PubMed ID: 37863651
[TBL] [Abstract] [Full Text] [Related]
12. Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma.
Augustin RC; Newman S; Li A; Joy M; Lyons M; Pham MP; Lucas P; Smith K; Sander C; Isett B; Davar D; Najjar YG; Zarour HM; Kirkwood JM; Luke JJ; Bao R
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37857525
[TBL] [Abstract] [Full Text] [Related]
13. Intrinsic Resistance to Osimertinib in EGFR Mutated NSCLC Cell Lines Induced by Alteration in Cell-Cycle Regulators.
Volta F; La Monica S; Leonetti A; Gnetti L; Bonelli M; Cavazzoni A; Fumarola C; Galetti M; Eltayeb K; Minari R; Petronini PG; Tiseo M; Alfieri R
Target Oncol; 2023 Nov; 18(6):953-964. PubMed ID: 37855989
[TBL] [Abstract] [Full Text] [Related]
14. A genetic variant in gene NDUFAF4 confers the risk of non-small cell lung cancer by perturbing hsa-miR-215 binding.
Long T; Li J; Yin T; Liu K; Wang Y; Long J; Wang J; Cheng L
Mol Carcinog; 2024 Jan; 63(1):145-159. PubMed ID: 37787384
[TBL] [Abstract] [Full Text] [Related]
15. Modified Bushen Yiqi formula enhances antitumor immunity by reducing the chemotactic recruitment of M2-TAMs and PMN-MDSCs in Lewis lung cancer-bearing mice.
Kong Q; Zhu H; Gong W; Deng X; Liu B; Dong J
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117183. PubMed ID: 37739106
[TBL] [Abstract] [Full Text] [Related]
16. Oral uracil-tegafur compared with intravenous chemotherapy as adjuvant therapy for resected early-stage non-small cell lung cancer patients.
Liang SK; Wu CW; Chang CI; Keng LT; Lee MR; Wang JY; Ko JC; Liao WY; Chen KY; Ho CC; Shih JY; Yu CJ
Cancer Med; 2023 Sep; 12(17):17993-18004. PubMed ID: 37559409
[TBL] [Abstract] [Full Text] [Related]
17. Cause-specific mortality by county, race, and ethnicity in the USA, 2000-19: a systematic analysis of health disparities.
GBD US Health Disparities Collaborators
Lancet; 2023 Sep; 402(10407):1065-1082. PubMed ID: 37544309
[TBL] [Abstract] [Full Text] [Related]
18. FSIP1 enhances the therapeutic sensitivity to CDK4/6 inhibitors in triple-negative breast cancer patients by activating the Nanog pathway.
Chen G; Sun L; Gu X; Ai L; Yang J; Zhang Z; Hou P; Wang Y; Ou X; Jiang X; Qiao X; Ma Q; Niu N; Xue J; Zhang H; Yang Y; Liu C
Sci China Life Sci; 2023 Dec; 66(12):2805-2817. PubMed ID: 37460715
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic Value of Pretreatment Serum Carcinoembryonic Antigen Level in 1130 Patients With Non-small Cell lung cancer: A Propensity Score Matching Cohort Study and Cumulative Meta-analysis.
Li F; Lv Q; Wang Y; Zhao S; Guo T; Wang G; Gu C
Am J Clin Oncol; 2023 Sep; 46(9):399-408. PubMed ID: 37390106
[TBL] [Abstract] [Full Text] [Related]
20. A novel risk signature for predicting brain metastasis in patients with lung adenocarcinoma.
Zhao Y; Gu S; Li L; Zhao R; Xie S; Zhang J; Zhou R; Tu L; Jiang L; Zhang S; Ma S
Neuro Oncol; 2023 Dec; 25(12):2207-2220. PubMed ID: 37379245
[TBL] [Abstract] [Full Text] [Related]
[Next]
